[Turicella otitidis, contributions to its role in the etiology of ear infections]
- PMID: 29696957
- PMCID: PMC6166263
[Turicella otitidis, contributions to its role in the etiology of ear infections]
Abstract
Objective: Turicella otitidis is a gram-positive bacillus coryneforme described, after 16S RNA sequencing, in 1994 by Funke et al as a microorganism involved in otitis media, and it is in health conditions a habitual colonizer of the external auditory canal. Since its description, more than twenty years ago, few cases of otitis related to or directly attributed to this microorganism have been published.
Methods: Description of a case of mastoiditis that required surgery and other cases of otic pathology in which T. otitidis was isolated, in the second semester of 2017 in our institution. They were reported only when they grew in pure culture. The identification was made by mass spectrophotometry and an antibiogram was performed.
Results: In our institution in the second half of 2017, 5 cases of otitis media were documented, some of them complicated, in which T. otitidis was isolated. The most of patients were children with recurrent otic pathology, and in some cases the sample was taken before the administration of antibiotics.
Conclusions: Since the inclusion of new vaccines that protect against microorganisms typically causing otitis media, is possible there are a change in the etiology of this disease and that microorganisms anecdotally isolated until now have become protagonists. The improvement in the microbiological identification provided by tools such as mass spectrometry will help to clarify if there are or not a change in the etiology of these diseases.
Introducción: Turicella otitidis es un bacilo grampositivo corineforme descrito, tras secuenciación de ARN 16S, en 1994 como microorganismo implicado en otitis media, siendo en condiciones de salud un colonizante habitual del conducto auditivo externo. Desde su descripción, hace ya más de veinte años, se han publicado pocos casos de otitis relacionados o directamente atribuidos a este microorganismo.
Método: Descripción de un caso de mastoiditis que requirió cirugía y resto de los casos de patología ótica en los que se aisló en cultivo puro T. otitidis, en el segundo semestre de 2017 en nuestra institución. La identificación se realizó por espectrofotometría de masas y se les realizó antibiograma.
Resultados: En nuestra institución se documentaron, en el segundo semestre de 2017, 5 casos de otitis media, alguna complicada, en las que se aisló T. otitidis. La mayoría de los pacientes eran niños y con patología ótica de repetición, y en alguno la toma de la muestra se realizó antes de la administración de antibióticos.
Conclusiones: Desde la inclusión de las nuevas vacunas que protegen frente a microorganismos típicamente causantes de otitis media es posible que asistamos a un cambio en la etiología de esta enfermedad y que adquieran protagonismo microorganismos hasta ahora de aislamiento anecdótico. La mejora en la identificación microbiológica que aportan herramientas como la espectrofotometría de masas definirá más claramente si existe o no este cambio.
©The Author 2018. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).
Conflict of interest statement
Los autores declaran no tener ningún conflicto de intereses.
Figures
Similar articles
-
Metabolism and gene sequence variation in Turicella otitidis implies its adaptability and pathogenicity in extra-otic infection: a systematic review.BMC Infect Dis. 2023 Oct 27;23(1):735. doi: 10.1186/s12879-023-08721-y. BMC Infect Dis. 2023. PMID: 37891485 Free PMC article.
-
[Turicella otitidis infection: otitis media complicated by mastoiditis].Arch Pediatr. 2009 Mar;16(3):243-7. doi: 10.1016/j.arcped.2008.12.011. Epub 2009 Jan 31. Arch Pediatr. 2009. PMID: 19181497 French.
-
Characterization, prognostic factors, and clinical profile of ear infections by Turicella otitidis: Revealing the emerging rise of a controversial pathogen.Am J Otolaryngol. 2025 Jan-Feb;46(1):104574. doi: 10.1016/j.amjoto.2024.104574. Epub 2024 Dec 19. Am J Otolaryngol. 2025. PMID: 39729793
-
Acute and chronic otitis media and Turicella otitidis: a controversial association.Clin Microbiol Infect. 2004 Sep;10(9):854-7. doi: 10.1111/j.1198-743X.2004.00965.x. Clin Microbiol Infect. 2004. PMID: 15355421
-
Turicella otitidis and Corynebacterium auris: 20 years on.Infection. 2014 Feb;42(1):1-4. doi: 10.1007/s15010-013-0488-x. Epub 2013 Jun 18. Infection. 2014. PMID: 23775360 Review.
Cited by
-
Panel 7 - Pathogenesis of otitis media - a review of the literature between 2015 and 2019.Int J Pediatr Otorhinolaryngol. 2020 Mar;130 Suppl 1:109838. doi: 10.1016/j.ijporl.2019.109838. Epub 2019 Dec 19. Int J Pediatr Otorhinolaryngol. 2020. PMID: 31879085 Free PMC article. Review.
-
Metabolism and gene sequence variation in Turicella otitidis implies its adaptability and pathogenicity in extra-otic infection: a systematic review.BMC Infect Dis. 2023 Oct 27;23(1):735. doi: 10.1186/s12879-023-08721-y. BMC Infect Dis. 2023. PMID: 37891485 Free PMC article.
-
[Isolation of Turicella otitidis in ear infection].Rev Esp Quimioter. 2021 Jun;34(3):264-266. doi: 10.37201/req/144.2020. Epub 2021 Mar 15. Rev Esp Quimioter. 2021. PMID: 33715319 Free PMC article. Spanish. No abstract available.
-
Turicella otitidis central venous-related bacteremia during pediatric acute lymphoblastic leukemia.Rev Esp Quimioter. 2023 Oct;36(5):531-532. doi: 10.37201/req/126.2022. Epub 2023 Jul 18. Rev Esp Quimioter. 2023. PMID: 37462015 Free PMC article. No abstract available.
-
[Turicella otitidis isolates in otic exudates during 2020].Rev Esp Quimioter. 2021 Aug;34(4):390-392. doi: 10.37201/req/011.2021. Epub 2021 Jun 3. Rev Esp Quimioter. 2021. PMID: 34081421 Free PMC article. Spanish. No abstract available.
References
-
- Correa L, González C, Gaona CE, Sánchez J. Otitis externa por Turicella otitidis: a propósito de dos casos. Rev Esp Quimioter 2017; 30(6): 474-5. PMID: . - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical